In the ALLHAT trial, cumulative event rates for the development of stroke according to primary treatment with chlorthalidone, amlodipine, or lisinopril. Compared to chlorthalidone, there was a significant increase in the six year rate of stroke with lisinopril (6.3 versus 5.6 percent, relative risk 1.15 95 percent CI 1.02 to 1.30).
Data from The ALLHAT Officers, JAMA 2002; 288:2981.
Graphic 61612 Version 1.0
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟